Physician profile
Yohan Song
NPI 1295122265
$691.47
in general payments reported to CMS, 2019-2025
8 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $294 · 2024: $121 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $147.20 | 2023 | |
| Aerin Medical INC. | $121.08 | 2024 | |
| Advanced Bionics, LLC | $118.53 | 2022-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Cochlear Americas | $116.44 | 2023-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Medtronic, INC. | $105.14 | 2023 | Stealthstation S8 Platform |
| Integra Lifesciences Corporation | $40.53 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Access Pro Medical, LLC | $25.69 | 2025 | Matriderm |
| Xeris Pharmaceuticals, INC. | $16.86 | 2023 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yohan Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.